nVerses Capital, LLC

SEC CIK: 0002011399
Latest filing: Aug 4, 2026

SEC filings (opens in a new tab)

OCUL holding history

Ocular Therapeutix, Inc in every 13F filed by nVerses Capital, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

OCUL overview All 13F holders of OCUL Full Q2 2026 holdings

Shares (Q2 2026): 26,117
Value: $256.5K
% of portfolio: 0.4%
Quarters held: 2; Since Q4 2023

Holdings of OCUL by nVerses Capital, LLC, by quarter
Quarter	Shares	Value	% of portfolio	Share change	Action	All holders
Q2 2026	26,117	$256.5K	0.4%	+26,117	New	Holders
Q1 2024	0	$0	0.0%	–	Sold out	Holders
Q4 2023	–	$12.5K	<0.1%	–	No prior filing	Holders